RxSight (RXST) Cash from Operations Growth (5y) (2025 - 2026)

RxSight (RXST) Cash from Operations Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.33 Bn 174.04 Bn 6.27 Bn
2 Stryker 128.11 Bn 125.23 Bn 3.81 Bn
3 Medtronic 107.76 Bn 98.54 Bn 6.41 Bn
4 Boston Scientific 67.95 Bn 66.50 Bn 3.61 Bn
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn
6 GE HealthCare Technologies 28.43 Bn 26.14 Bn 1.98 Bn
7 Dexcom 28.31 Bn 27.20 Bn 750.30 Mn
8 Smith & Nephew 26.77 Bn 26.19 Bn -
9 Koninklijke Philips 25.33 Bn 22.21 Bn 2.07 Bn
10 RxSight 227.10 Mn -191.11 Mn 23.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.22%
Dec 31, 2025 32.94%
Sep 30, 2025 29.77%